NIO Stock Prediction and Forecast [NIO]

AI-generated source summary

The analysis of NIO stock presents mixed signals across various timeframes. The short-term moving average indicates a buy signal, contrasting with a general sell signal from the long-term average, suggesting a negative short-term outlook. The stock currently trades at $4.67, with immediate support identified at $4.64 and resistance at $4.78. Over the next three months, a decline of approximately 35.56% is projected, with potential returns ranging from -43.76% to -30.8%. Daily volatility averaged 3.13% over the past week, with an overall medium risk assessment. A divergence between falling volume and rising prices on the last trading day serves as an early warning. Analyst ratings show a mix of "Outperform" and "Neutral/Downgrade" recommendations. Fundamentally, the stock's Price-to-Earnings ratio is negative, signaling losses, and the upcoming earnings report on March 20, 2026, anticipates a loss of 7 cents per share. The recommended stop-loss is set at $4.43. The overall conclusion labels NIO as a "Hold/Accumulate" candidate, an upgrade from a previous "Sell" recommendation, yet the current price is considered overvalued, with an expected lower open for the next trading session.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   22 Jan 2026, 04:52 UTC

   The analyst published the original source item.

2. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

3. Market predictions extracted

   18 May 2026, 20:48 UTC

   1 eligible signal linked to this case.

4. Outcome tracking started

   02 Jul 2026, 02:13 UTC

   Tahlil Plus began monitoring the extracted predictions.

5. First prediction resolved

   02 Jul 2026, 02:13 UTC

   The first evaluable outcome in this case reached a terminal result.

6. Case evaluation completed

   02 Jul 2026, 02:13 UTC

   All evaluable predictions in this case reached terminal outcomes.